Zane L, Sharma V, Misteli T. Common features of chromatin in aging and cancer: cause or coincidence? Trends Cell Biol 2014;24(11):686-94.
DOI: 10.1016/j.tcb.2014.07.001
Weaver KE, Leach CR, Leng X, et al. Physical functioning among women 80 years of age and older with and without a cancer history. J Gerontol A Biol Sci Med Sci 2016;71 (Suppl. 1):S23-30.
DOI: 10.1093/gerona/glv073
Mohile SG, Xian Y, Dale W, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst 2009;101(17):1206-15.
DOI: 10.1093/jnci/djp239
Wildiers H, Heeren P, Puts M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 2014;32(24):2595-603.
DOI: 10.1200/JCO.2013.54.8347
Molina Garrido MJ. Oncogeriatría: una forma de optimizar la atención global del paciente anciano con cáncer. Nutr Hosp 2016;33(Supl. 1):177.
DOI: 10.20960/nh.177
Puts MTE, Strohschein FJ, del Giudice ME, et al. Role of the geriatrician, primary care practitioner, nurses, and collaboration with oncologists during cancer treatment delivery for older adults: A narrative review of the literature. J Geriatr Oncol 2018;9(4):398-404.
DOI: 10.1016/j.jgo.2018.04.008
http://www.who.int/cancer/country-profiles/en/
https://seer.cancer.gov/csr/1975_2015/results_merged/topic_age_dist.pdf
Aparicio T, Jouve JL, Teillet L, et al. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. J Clin Oncol 2013;31(11):1464-70.
DOI: 10.1200/JCO.2012.42.9894
Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011;29(25):3457-65.
DOI: 10.1200/JCO.2011.34.7625
Wildes TM, Ruwe AP, Fournier C, et al. Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer. J Geriatr Oncol 2013;4(3):227-34.
DOI: 10.1016/j.jgo.2013.02.002
Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High- Age Patients (CRASH) score. Cancer 2012;118:3377-86.
DOI: 10.1002/cncr.26646
Marinello R, Marenco D, Roglia D, et al. Predictors of treatment failures during chemotherapy: A prospective study on 110 older cancer patients. Arch Gerontol Geriatr 2009;48:222-6.
DOI: 10.1016/j.archger.2008.01.011
Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005;16(11):1795-800.
DOI: 10.1093/annonc/mdi368
Popa IE, Stewart K, Smith FP, et al. A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma. Cancer 2002;95(8):1714-9.
DOI: 10.1002/cncr.10843
Hurria A, Fleming MT, Baker SD, et al. Pharmacokinetics and toxicity of weekly docetaxel in older patients. Clin Cancer Res 2006;12(20 Pt 1):6100-5.
DOI: 10.1158/1078-0432.CCR-06-0200
Biesma B, Wymenga AN, Vincent A, et al; Dutch Chest Physician Study Group. Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol 2011;22:1520-7.
DOI: 10.1093/annonc/mdq637
Fisher S, Al-Fayea TM, Winget M, et al. Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival. J Cancer Epidemiol 2012;2012:708936.
DOI: 10.1155/2012/708936
Kim JW, Kim YJ, Lee KW, et al. The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer 2014;22:773-81.
DOI: 10.1007/s00520-013-2033-y
Fairfield KM, Murray K, Lucas FL, et al. Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer. J Clin Oncol 2011;29(29):3921-6.
DOI: 10.1200/JCO.2010.34.1552
Frasci G, Lorusso V, Panza N, et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18(13):2529-36.
DOI: 10.1200/JCO.2000.18.13.2529
Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 2011;79:205-12.
DOI: 10.1016/j.critrevonc.2010.05.009
Hoppe S, Rainfray M, Fonck M, et al. Functional decline in older patients with cancer receiving first-line chemotherapy. J Clin Oncol 2013;31(31):3877-82.
DOI: 10.1200/JCO.2012.47.7430
Hurria A, Rosen C, Hudis C, et al. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study. J Am Geriatr Soc 2006;54:925-31.
DOI: 10.1111/j.1532-5415.2006.00732.x
Hurria A, Goldfarb S, Rosen C, et al. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective. Breast Cancer Res Treat 2006;98:343-8.
DOI: 10.1007/s10549-006-9171-6
Buist DS, Chubak J, Prout M, et al. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol 2009;27(27):4508-14.
DOI: 10.1200/JCO.2008.18.3459
Molina-Garrido MJ, Guillén-Ponce C. Under-use of adjuvant chemotherapy in women aged ≥70 years diagnosed with breast cancer in a university hospital. Rev Esp Geriatr Gerontol 2012;47(1):15-8.
DOI: 10.1016/j.regg.2011.06.007
Maas HA, Kruitwagen RF, Lemmens VE, et al. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol 2005;97:104-9.
DOI: 10.1016/j.ygyno.2004.12.026
Doat S, Thiébaut A, Samson S, et al. Elderly patients with colorectal cancer: treatment modalities and survival in France. National data from the ThInDiT cohort study. Eur J Cancer 2014;50(7):1276-83.
DOI: 10.1016/j.ejca.2013.12.026
Serra-Rexach JA, Jiménez AB, García-Alhambra MA, et al. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist 2012;17(10):1277-85.
DOI: 10.1634/theoncologist.2012-0060
Gironés R. Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians. J Cancer Educ 2015;30(4):766-73.
DOI: 10.1007/s13187-014-0760-5
Extermann M, Albrand G, Chen H, et al. Are older French patients as willing as older American patients to undertake chemotherapy? J Clin Oncol 2003;21:3214-9.
DOI: 10.1200/JCO.2003.08.091
Stuck AE, Siu AL, Wieland GD, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993;342(8878):1032-6.
DOI: 10.1016/0140-6736(93)92884-V
Schulkes KJ, Hamaker ME, van den Bos F, et al. Relevance of a Geriatric Assessment for Elderly Patients with Lung Cancer-A Systematic Review. Clin Lung Cancer 2016;17(5):341-9.
DOI: 10.1016/j.cllc.2016.05.007
Molina-Garrido MJ, Guillén-Ponce C. Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review Aging Male 2017;20(2):102-9.
DOI: 10.1080/13685538.2016.1277516
Molina-Garrido MJ, Guillén-Ponce C, Blanco R, et al; Working Group on Oncogeriatrics of the Spanish Society of Medical Oncology (SEOM). Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain. J Geriatr Oncol 2018;9(4):337-45.
DOI: 10.1016/j.jgo.2017.11.012
Molina-Garrido MJ, Soriano Rodríguez MC, Guillén-Ponce C. What is the role of the comprehensive geriatric assessment in Geriatric Oncology? Rev Esp Geriatr Gerontol 2019;54(1):27-33.
Hamaker ME, Wildes TM, Rostoft S. Time to Stop Saying Geriatric Assessment Is Too Time Consuming. J Clin Oncol 2017;35(25):2871-4.
DOI: 10.1200/JCO.2017.72.8170
Kenis C, Heeren P, Bron D, et al. Multicenter implementation of geriatric assessment in Belgian patients with cancer: a survey on treating physicians’ general experiences and expectations. J Geriatr Oncol 2014;431-8.
DOI: 10.1016/j.jgo.2014.09.093
Kalsi T, Babic-Illman G, Ross PJ, et al. The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer 2015;112:1435-44.
DOI: 10.1038/bjc.2015.120
Mohile SG, Dale W, Somerfield MR, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol 2018;36(22):2326-47.
DOI: 10.1200/JCO.2018.78.8687
Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, et al. The effect of a geriatric evaluation on treatment decisions for older cancer patients-a systematic review. Acta Oncol 2014;53:289-96.
DOI: 10.3109/0284186X.2013.840741
Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol 2011;29(27):3636-42.
DOI: 10.1200/JCO.2010.31.0664
Kenis C, Bron D, Libert Y, et al. Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study. Ann Oncol 2013;24(5):1306-12.
DOI: 10.1093/annonc/mds619
mds619
Jensen GL, Cederholm T, Isabel M, et al. JPEN J Parenter Enteral Nutr 2019;43:32-40.
Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: role of the Patient-Generated Subjective Global Assessment. Curr Opin Clin Nutr Metab Care 2017;20(5):322-9.
DOI: 10.1097/MCO.0000000000000389
Kyle UG, Bosaeus I, de Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430-53.
DOI: 10.1016/j.clnu.2004.09.012